← Back to headlines





China's AI Advances in Cancer Screening and Rare Disease Diagnosis
Chinese companies are making significant strides in personalized medicine, utilizing AI to boost cancer screening and rare disease diagnosis, with firms like MGI Tech and BGI Genomics leading in gene sequencing.
2 Mar, 05:00 — 2 Mar, 05:00
ℹOnly 1 source covers this story
Related Stories

Apple's Cheaper Smartphone is Coming, the iPhone 17e Has Been Introduced
3m ago

Netflix Ends Support for PlayStation 3, Affecting Millions of Users
5m ago

DeepSeek Launches New AI Version, Posing Challenge to US Rivals
8m ago

Danish Telecom Companies Invest DKK 100 Million to Improve Mobile Coverage by 2026
11m ago